Funds holding CUE BIOPHARMA INC
ISIN US22978P1066 · United States · LEI 549300PBW78KZA33WC97
- Fund holders
- 0
This issuer has other securities: Cue Biopharma Inc (US22978P2056)
No tracked fund declares this company in its latest report.
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 7 | +1 | 3,118,305 | -0.1 % |
| 2026Q1 | 6 | -1 | 3,121,466 | -1.2 % |
| 2025Q4 | 7 | 0 | 3,159,788 | -15.9 % |
| 2025Q3 | 7 | -2 | 3,757,214 | +25.7 % |
| 2025Q2 | 9 | -1 | 2,990,066 | +14.0 % |
| 2025Q1 | 10 | -3 | 2,623,323 | +0.5 % |
| 2024Q4 | 13 | -46 | 2,609,631 | -38.4 % |
| 2024Q3 | 59 | -23 | 4,238,800 | -16.0 % |
| 2024Q2 | 82 | -2 | 5,047,740 | -1.6 % |
| 2024Q1 | 84 | -3 | 5,128,842 | +3.6 % |
| 2023Q4 | 87 | 4,949,972 |
Institutional managers
50 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Bleichroeder LP | 6,819,164 | 1.6M $ | as of Mar 31, 2026 |
| GC Wealth Management RIA, LLC | 4,631,644 | 1.1M $ | as of Mar 31, 2026 |
| Lion Point Capital, LP | 2,202,854 | 506.4K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,064,690 | 244.8K $ | as of Mar 31, 2026 |
| Robertson Stephens Wealth Management, LLC | 478,500 | 110K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 449,161 | 103.3K $ | as of Mar 31, 2026 |
| Texas Capital Bank Wealth Management Services Inc | 397,421 | 91.4K $ | as of Mar 31, 2026 |
| ANGELES WEALTH MANAGEMENT, LLC | 310,000 | 71.3K $ | as of Mar 31, 2026 |
| ADVISORY RESEARCH INC | 257,225 | 59.1K $ | as of Mar 31, 2026 |
| STIFEL FINANCIAL CORP | 246,556 | 56.7K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 213,828 | 49.2K $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 207,708 | 47.6K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 179,353 | 41.2K $ | as of Mar 31, 2026 |
| DIADEMA PARTNERS LP | 131,997 | 30.3K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 94,606 | 21.8K $ | as of Mar 31, 2026 |
| UBS Group AG | 88,350 | 20.3K $ | as of Mar 31, 2026 |
| Chicago Partners Investment Group LLC | 85,937 | 49.9K $ | as of Mar 31, 2026 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 79,500 | 18.3K $ | as of Mar 31, 2026 |
| ADVISORTRUST PARTNERS, LLC | 50,000 | 11.5K $ | as of Mar 31, 2026 |
| Virtu Financial LLC | 49,553 | 11 $ | as of Mar 31, 2026 |
| Sigma Planning Corp | 38,750 | 8.9K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 34,151 | 7.9K $ | as of Mar 31, 2026 |
| Persistent Asset Partners Ltd | 33,369 | 7.7K $ | as of Mar 31, 2026 |
| Visionary Wealth Advisors | 29,285 | 6.7K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 24,614 | 5.7K $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding CUE BIOPHARMA INC". https://titelia.com/en/stocks/cue-biopharma-inc-US22978P1066